ArticleTherapeutic advances in medical oncology2019

Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience.

Raffaella Palumbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.